Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eukaryotic expression vectors and immunoconjugates for cancer therapy.

E M Glinka1, E F Edelweiss, S M Deyev

  • 1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia. em_glinka@mail.ru

Biochemistry. Biokhimiia
|July 11, 2006
PubMed
Summary

This review explores enhancing targeted anticancer therapies. Strategies include using tumor-specific promoters and antibody fusion proteins for improved specificity and efficacy in cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT/PDT therapy and optical bioimaging.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Uptake and Retention of Laser-synthesized Boron Nanoparticles in Tumor Cells and Fibroblasts.

Doklady. Biochemistry and biophysics·2026
Same author

The effect of dimeric bisbenzimidazoles on the activity of DNA repair enzymes TDP1, TDP2, PARP1 and PARP2.

Vavilovskii zhurnal genetiki i selektsii·2026
Same author

Synthesis and Pharmacokinetics of Nanosized NH<sub>2</sub>‑UiO‑66 (Zr) Metal-Organic Frameworks.

Doklady. Biochemistry and biophysics·2026
Same author

Targeted Radionuclide Detection of Malignant Tumors Using Affibody.

Acta naturae·2026
Same author

Targeted Nanoliposomes for the Delivery of Boronophenylalanine into HER2-Positive Cells.

Acta naturae·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy
  • Immunotherapy

Background:

  • Targeted anticancer agents require high specificity to minimize off-target effects and maximize therapeutic efficacy.
  • Current strategies for enhancing specificity include transcriptional targeting and antibody-based approaches.

Purpose of the Study:

  • To review and analyze strategies for improving the specificity of targeted anticancer therapies.
  • To discuss the integration of gene therapy and antibody therapy for novel antitumor treatment approaches.

Main Methods:

  • Analysis of transcriptional activation using tissue- and tumor-specific promoters in eukaryotic expression vectors.
  • Review of antitumor-directed immunoconjugates, focusing on antibody fusion proteins.

Related Experiment Videos

  • Examination of vector design for encoding secreted forms of immunoconjugates.

    • Main Results:

    • Identification of strategies for selecting targeted promoters that enhance specificity.
    • Examples of antibody fusion proteins demonstrating significant antitumor activity.
    • Development of vectors enabling intracellular synthesis and secretion of targeted immunoconjugates.

    Conclusions:

    • Combining gene therapy and antibody therapy offers a promising new direction for antitumor treatment.
    • Engineered vectors encoding secreted immunoconjugates can lead to sustained, targeted therapeutic agent delivery.
    • Enhanced specificity in targeted anticancer agents is achievable through advanced molecular and immunological strategies.